Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05698303
Title A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nanjing IASO Biotherapeutics Co.,Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.